Delivery Order SPE2DB22D1041-SPE2DB24FUDA8

Award Date 8/7/24
Potential Completion Date 8/8/24
Potential Value $8.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Medical Supply Chain. The contract is for the delivery of Rifampin 300mg capsules, a pharmaceutical product, with a ceiling value of $106,743.73 and a performance period through June 18, 2025. The contract is a Firm Fixed Price, non-set-aside award. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This is a $18,739.89 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the supply of Rifampin 300 mg capsules, with a period of performance through July 26, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999, to provide a wide range of essential...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 300 mg rifampin capsules. The $2,321.04 firm fixed price contract has an ultimate completion date of August 13, 2024. This order is not associated with a set-aside program. AmerisourceBergen, through its extensive pharmaceutical supply chain network, will provide these critical prescription medications to support military treatment...
This is a $5,348.56 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of Rifampin 150 mg capsules, with a performance period through May 20, 2025. Amerisourcebergen Drug Corp is a for-profit organization and a critical supplier of medical and pharmaceutical products to federal agencies, including the military healthcare system. The company holds a significant...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical to provide 4,565,453,612 units of the drug Rifampin 300 mg capsules. The contract is a Delivery Order with a Firm Fixed Price of $13,361.76 and has an ultimate completion date of August 15, 2024. The contract is not designated as a Set-Aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $2,132.20, is for the delivery of 60 capsules of the pharmaceutical product Rifampin 300 mg. The contract is a firm fixed price delivery order with a period of performance through March 29, 2024. Amerisourcebergen Drug Corp, based in...
The U.S. Defense Logistics Agency (DLA) has awarded a $29,964.06 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp for the supply of 4,565,470 units of Rifampin 300 mg capsules. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Amerisourcebergen, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical commodities to support military treatment programs and...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The $1,351.97 firm-fixed-price delivery order is for the supply of Rifampin 150 mg capsules. The contract has a period of performance through September 23, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and other federal agencies, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,782.72 firm fixed-price delivery order is for the supply of 300 mg Rifampin capsules. The contract has an ultimate completion date of February 7, 2025 and is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,160,692 units of Rifampin 300 mg capsules. The contract has a ceiling value of $5,109.58 and a period of performance through May 7, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract...
  • SPE2DB22D1041
    Indefinite Delivery Contract
  • SPE2DB22D1041-SPE2DB24FUDA8
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Rifampin 300 mg capsules. The $8,227.77 firm fixed-price contract has an ultimate completion date of August 8, 2024. Amerisourcebergen is delivering these pharmaceutical products under a larger indefinite delivery contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This contract award does not include a set-aside designation.

Generated 11/6/24, 9:03 AM